BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16760550)

  • 1. Newborn hearing screening in Hong Kong.
    Lam BC
    Hong Kong Med J; 2006 Jun; 12(3):212-8. PubMed ID: 16760550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening.
    Grill E; Uus K; Hessel F; Davies L; Taylor RS; Wasem J; Bamford J
    BMC Health Serv Res; 2006 Feb; 6():14. PubMed ID: 16504089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of neonatal hearing screening program in China: should universal screening be prioritized?
    Huang LH; Zhang L; Tobe RY; Qi FH; Sun L; Teng Y; Ke QL; Mai F; Zhang XF; Zhang M; Yang RL; Tu L; Li HH; Gu YQ; Xu SN; Yue XY; Li XD; Qi BE; Cheng XH; Tang W; Xu LZ; Han DM
    BMC Health Serv Res; 2012 Apr; 12():97. PubMed ID: 22510223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected cost-effectiveness of statewide universal newborn hearing screening.
    Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
    Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of long-term impacts of universal newborn hearing screening.
    Chiou ST; Lung HL; Chen LS; Yen AM; Fann JC; Chiu SY; Chen HH
    Int J Audiol; 2017 Jan; 56(1):46-52. PubMed ID: 27598544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A programme of studies including assessment of diagnostic accuracy of school hearing screening tests and a cost-effectiveness model of school entry hearing screening programmes.
    Fortnum H; Ukoumunne OC; Hyde C; Taylor RS; Ozolins M; Errington S; Zhelev Z; Pritchard C; Benton C; Moody J; Cocking L; Watson J; Roberts S
    Health Technol Assess; 2016 May; 20(36):1-178. PubMed ID: 27169435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economics of screening infants at risk of hearing impairment: an international analysis.
    Burke MJ; Shenton RC; Taylor MJ
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):212-8. PubMed ID: 22129917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of implementing a universal neonatal hearing screening programme using distortion product otoacoustic emission detection at a university hospital in Hong Kong.
    Ng PK; Hui Y; Lam BC; Goh WH; Yeung CY
    Hong Kong Med J; 2004 Feb; 10(1):6-13. PubMed ID: 14967849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal knowledge and attitudes to universal newborn hearing screening: Reviewing an established program.
    Lam MYY; Wong ECM; Law CW; Lee HHL; McPherson B
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():146-153. PubMed ID: 29447803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of universal newborn screening for bilateral permanent congenital hearing impairment: systematic review.
    Colgan S; Gold L; Wirth K; Ching T; Poulakis Z; Rickards F; Wake M
    Acad Pediatr; 2012; 12(3):171-80. PubMed ID: 22583631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and performance of early hearing detection programmes in Lagos, Nigeria.
    Olusanya BO; Emokpae A; Renner JK; Wirz SL
    Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):179-86. PubMed ID: 18814895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and test-performance factors in relation to universal newborn hearing screening.
    Gorga MP; Neely ST
    Ment Retard Dev Disabil Res Rev; 2003; 9(2):103-8. PubMed ID: 12784228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the costs of implementing the National Newborn Hearing Screening Programme in England.
    Uus K; Bamford J; Taylor R
    J Med Screen; 2006; 13(1):14-9. PubMed ID: 16569300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost analysis of a universal newborn hearing screening for clinics using the State of Hesse as an example].
    Böttcher P; Gramss M; Euler HA; Neumann K
    HNO; 2009 Jan; 57(1):21-8. PubMed ID: 19145419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration of expanded newborn screening in Hong Kong.
    Lee HH; Mak CM; Poon GW; Wong KY; Lam CW
    J Med Screen; 2014 Jun; 21(2):61-70. PubMed ID: 24803483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of the promotion of newborn hearing screening in Taiwan.
    Huang CM; Yang IY; Ma YC; Lin GS; Yang CC; Tsai HT; Lin HC
    Int J Pediatr Otorhinolaryngol; 2014 Jan; 78(1):14-8. PubMed ID: 24300945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
    Lee PM; Wong KH
    Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment.
    Davis A; Bamford J; Wilson I; Ramkalawan T; Forshaw M; Wright S
    Health Technol Assess; 1997; 1(10):i-iv, 1-176. PubMed ID: 9483157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The universal newborn hearing screening in Brazil: from identification to intervention.
    Bevilacqua MC; Alvarenga Kde F; Costa OA; Moret AL
    Int J Pediatr Otorhinolaryngol; 2010 May; 74(5):510-5. PubMed ID: 20303604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
    Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
    JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.